Heplisav-B Dosage

Dose and Regimen

Administer intramuscularly as a series of 2 doses (0.5-mL dose each) at the following schedule: 0, 1 month.

Administration

HEPLISAV-B is a clear to slightly opalescent, colorless to slightly yellow solution.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered.

Administer HEPLISAV-B by intramuscular injection in the deltoid region using a sterile needle and syringe.